Professor Matt Sydes explains how we’re semi-automating the data provenance process to ease the admin burden on researchers and speed up clinical trials.
A hard truth is that we need to improve the delivery of clinical trials. They are often large and time consuming for good reason. We need reliable findings and must protect against false positives and false negatives.
If patients are already expected to do well or the treatment is only expected to make a modest improvement or we need to have greater certainty of the results, the trial will need to be larger and longer. And more time inevitably means more money.
